Table 2.

Uptake of idarubicin and doxorubicin in tumors when delivered by SDDS in combination with hyperthermia

	Uptake efficiency (%ID/g tumor)		Uptake absolute quantity (nmol/g tumor)
	#Low dosage	High dosage	Low dosage	High dosage
IDA	13.6 ± 2.2*	13.0 ± 3.6*	15.4 ± 3.5*	43.8 ± 9.7*
DXR	4.5 ± 0.4	8.4 ± 0.7	4.2 ± 0.5	25.2 ± 2.2

# Low dosage: 2.7 µmol/kg; High dosage: 9 µmol/kg;

IDA: idarubicin, DXR: doxorubicin;

Data are presented as mean ± SD, N = 3;

*p < 0.05.